Recent Updates
Recently added Catalysts
TMDX Positive Sentiment Score: 70/100

TransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference TransMedics Group, Inc. ( TransMedics ) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...

Key Takeaway: TransMedics Group, Inc. has announced its participation in the Piper Sandler 35th Annual Healthcare Conference, scheduled for November 28, 2023. The management team will engage in a fireside chat at 2:30 p.m. ET. The event aims to spotlight TransMedics' innovative technologies aimed at improving organ transplant therapies for patients with end-stage organ failure. The conference is a significant occasion for the company to showcase its leadership in the transplantation market.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent healthcare conference indicates company growth and visibility.
  • TransMedics is recognized as a leader in organ transplant technology.
  • Potential to discuss advancements in organ preservation and utilization at the event.

Full Press Release Details

ANDOVER, Mass. , Nov. 14, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX ), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Piper Sandler 35 th Annual Healthcare Conference in New York . The fireside chat will take place on Tuesday, November 28, 2023 , at 2:30 p.m. Eastern Time .
Event: Piper Sandler 35 th Annual Healthcare Conference Date: Tuesday, November 28, 2023 Time: 2:30 p.m. ET
A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/ .
About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts , the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
Investor Contact: Brian Johnston 332-895-3222 [email protected]
SOURCE TransMedics Group, Inc.

21 %

Frequently Asked Questions

What is TransMedics Group, Inc. known for?

TransMedics specializes in portable warm perfusion and organ assessment for transplants.

When is the fireside chat at the Piper Sandler Conference?

The chat is scheduled for November 28, 2023, at 2:30 p.m. Eastern Time.

Where can I watch the fireside chat webcast?

The webcast will be available in the 'Investors' section of TransMedics' website.

What issue does TransMedics aim to address?

TransMedics focuses on improving the availability and quality of transplant organs.

Where is TransMedics headquartered?

TransMedics is headquartered in Andover, Massachusetts.

Last updated: Nov 14, 2023